GPT and cancer: Due to the near universal loss of the SWI/SNF protein ATRX in ALT cancer, and the ability of ATRX to suppress markers of ALT in a DAXX dependent manner, it would appear that loss of ATRX is a key factor in the development of ALT (27–29).